Blood Res 2018; 53(1): 9-9  https://doi.org/10.5045/br.2018.53.1.9
Renal cell carcinoma metastasizing to the myeloproliferative bone marrow
Thein Hlaing Oo1*, and Roberto Nicolas Miranda2

1Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.

2Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.

Correspondence to: Thein Hlaing Oo, M.D., Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1464, Houston, TX 77030, USA. theinoomd@gmail.com, thoo@mdanderson.org
Received: May 6, 2017; Accepted: July 2, 2017; Published online: March 31, 2018.
© The Korean Journal of Hematology. All rights reserved.

cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


e-submission

This Article

Current Issue

ba_link01

Indexed/Covered by

Today : 141  /
Total : 201,519